Chartwell Investment Partners, LLC Liquidia Corp Transaction History
Chartwell Investment Partners, LLC
- $2.85 Billion
- Q2 2024
A detailed history of Chartwell Investment Partners, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Chartwell Investment Partners, LLC holds 43,693 shares of LQDA stock, worth $481,059. This represents 0.02% of its overall portfolio holdings.
Number of Shares
43,693
Previous 50,833
14.05%
Holding current value
$481,059
Previous $750,000
30.13%
% of portfolio
0.02%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding LQDA
# of Institutions
163Shares Held
36MCall Options Held
1.79MPut Options Held
380K-
Patient Square Capital LP Menlo Park, CA7.18MShares$79.1 Million40.01% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$46.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$37.5 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY2.4MShares$26.4 Million13.89% of portfolio
-
State Street Corp Boston, MA2.23MShares$24.6 Million0.0% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $709M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...